These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 3172360

  • 1. Uptake of estramustine phosphate (estracyt) metabolites in prostatic cancer.
    Norlén BJ, Andersson SB, Björk P, Gunnarsson PO, Fritjofsson A.
    J Urol; 1988 Nov; 140(5):1058-62. PubMed ID: 3172360
    [Abstract] [Full Text] [Related]

  • 2. Accumulation of estramustine and estromustine in adipose tissue of rats and humans.
    Gunnarsson PO, Andersson SB, Sandberg AA, Ellman M.
    Cancer Chemother Pharmacol; 1991 Nov; 28(5):361-4. PubMed ID: 1914079
    [Abstract] [Full Text] [Related]

  • 3. [Pharmacology and metabolism of a new therapeutic drug for prostatic cancer "Estracyt"].
    Yamanaka H, Shida K.
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):537-44. PubMed ID: 6422861
    [Abstract] [Full Text] [Related]

  • 4. Plasma concentrations of estramustine phosphate and its major metabolites in patients with prostatic carcinoma treated with different doses of estramustine phosphate (Estracyt).
    Gunnarsson PO, Forshell GP, Fritjofsson A, Norlén BJ.
    Scand J Urol Nephrol; 1981 Mar; 15(3):201-5. PubMed ID: 7323739
    [Abstract] [Full Text] [Related]

  • 5. [Estracyt (estradiol-nitrogen mustard complex)--estramustine binding protein and its specificity].
    Yamanaka H, Imai K, Suzuki T, Yuasa H, Takahashi E.
    Gan To Kagaku Ryoho; 1984 Oct; 11(10):2106-14. PubMed ID: 6486830
    [Abstract] [Full Text] [Related]

  • 6. Impairment of estramustine phosphate absorption by concurrent intake of milk and food.
    Gunnarsson PO, Davidsson T, Andersson SB, Backman C, Johansson SA.
    Eur J Clin Pharmacol; 1990 Oct; 38(2):189-93. PubMed ID: 2338118
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics of estramustine phosphate (Estracyt) in prostatic cancer patients.
    Gunnarsson PO, Andersson SB, Johansson SA, Nilsson T, Plym-Forshell G.
    Eur J Clin Pharmacol; 1984 Oct; 26(1):113-9. PubMed ID: 6714283
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Uptake and retention of estramustine and the presence of estramustine binding protein in malignant brain tumours in humans.
    Bergenheim AT, Gunnarsson PO, Edman K, von Schoultz E, Hariz MI, Henriksson R.
    Br J Cancer; 1993 Feb; 67(2):358-61. PubMed ID: 8431366
    [Abstract] [Full Text] [Related]

  • 10. Metabolism of estramustine phosphate (Estracyt) in patients with prostatic carcinoma.
    Andersson SB, Gunnarsson PO, Nilsson T, Forshell GP.
    Eur J Drug Metab Pharmacokinet; 1981 Feb; 6(2):149-54. PubMed ID: 7274309
    [Abstract] [Full Text] [Related]

  • 11. Binding sites for the cytotoxic metabolites of estramustine phosphate (Estracyt) in rat and human pancreas that are distinct from pancreatic estrogen-binding protein.
    Björk P, Jönsson U, Andrén-Sandberg A.
    Pancreas; 1991 Jan; 6(1):77-89. PubMed ID: 1994382
    [Abstract] [Full Text] [Related]

  • 12. Androgen antagonistic effect of estramustine phosphate (EMP) metabolites on wild-type and mutated androgen receptor.
    Wang LG, Liu XM, Kreis W, Budman DR.
    Biochem Pharmacol; 1998 May 01; 55(9):1427-33. PubMed ID: 10076535
    [Abstract] [Full Text] [Related]

  • 13. Partial characterization and "quantitation" of a human prostatic estramustine-binding protein.
    Björk P, Forsgren B, Gustafsson JA, Pousette A, Högberg B.
    Cancer Res; 1982 May 01; 42(5):1935-42. PubMed ID: 7066904
    [Abstract] [Full Text] [Related]

  • 14. Estramustine phosphate: plasma concentrations of its metabolites following oral administration to man, rat and dog.
    Dixon R, Brooks M, Gill G.
    Res Commun Chem Pathol Pharmacol; 1980 Jan 01; 27(1):17-29. PubMed ID: 7360997
    [Abstract] [Full Text] [Related]

  • 15. [Clinical effects of estramustine phosphate disodium (Estracyt) on prostatic cancer].
    Nishio S, Kishimoto T, Maekawa M, Kawakita J, Hayahara N, Yuki K, Morikawa Y, Yasumoto R, Kato Y, Funai K.
    Hinyokika Kiyo; 1986 Nov 01; 32(11):1763-70. PubMed ID: 3825823
    [Abstract] [Full Text] [Related]

  • 16. Expression of an estramustine-binding associated protein in human lung cancer cell lines.
    Bergh J, Björk P, Westlin JE, Nilsson S.
    Cancer Res; 1988 Aug 15; 48(16):4615-9. PubMed ID: 2840198
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Mechanism of retention of estramustine in the rat prostate and results of a clinical trial of Estracyt in Japan.
    Yamanaka H, Imai K, Yuasa H, Shida K.
    Prostate; 1981 Aug 15; Suppl 1():95-102. PubMed ID: 7043423
    [Abstract] [Full Text] [Related]

  • 19. Estramustine phosphate (Estracyt): experimental and clinical studies in Europe.
    Hoisaeter PA, Bakke A.
    Semin Oncol; 1983 Sep 15; 10(3 Suppl 3):27-33. PubMed ID: 6364363
    [No Abstract] [Full Text] [Related]

  • 20. The presence in rat and human prostate of proteins that bind steroid-cytostatic complexes.
    Forsgren B, Björk P, Carlström K, Gustafsson JA, Pousette A, Högberg B.
    Prog Clin Biol Res; 1981 Sep 15; 75A():391-407. PubMed ID: 7339627
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.